Improvements in anxiety were correlated with an alleviation in respiratory strain. Results imply that hypnosis can contribute to the improvement of anxiety levels and breathing mechanics in severe COPD patients.

ISRCTN10029862.

ISRCTN10029862.

The Global Initiative for Chronic Obstructive Lung Disease 2020 report recommends that patients with chronic obstructive pulmonary disease (COPD) suffering from persistent dyspnea, despite long-acting β

-agonist (LABA)/inhaled corticosteroid (ICS) maintenance therapy, are switched to either a long-acting muscarinic antagonist (LAMA)/LABA combination regimen or LAMA/LABA/ICS triple therapy. However, to date, no studies have investigated the direct switch from LABA/ICS to LAMA/LABA therapy-instead of switching to triple therapy-in a prospective, real-world, non-interventional setting.

EVELUT

(NCT03954132) is an ongoing, prospective, open-label, multicenter, non-interventional study comparing the once-daily fixed-dose combination of tiotropium and olodaterol (tio/olo) versus any triple therapy (LAMA/LABA/ICS) in patients with COPD who are symptomatic despite LABA/ICS maintenance therapy. Patients with acute or frequent COPD exacerbations are excluded from the study. Participants will receive LABA/ICS main EUPAS29784; the Federal Institute for Drugs and Medical Devices (BfArM) NIS Study No 7305; Clinicaltrials.gov NCT03954132.

To enumerate students who accepted/would accept treatment by dental student peers (DSP), describe characteristics of DSP and explore factors associated with determining DSP treatment.

A 17-item online survey was distributed to students of all levels (383) at Taibah University Dental College and Hospital during the academic year 2019-2020. The survey comprised three sections section one asked questions about the students’ demographics and socioeconomics (family income), section two focused on the acceptance of treatment by DSP, characteristics of DSP, and section three asked about factors influencing acceptance of treatment by DSP. The collected data underwent descriptive, bivariate and logistic regression analyses.

Of 383 students, 222 (58%) completed the survey; 72 (32%) were at an intern level and 150 (68%) at other levels. Those who had accepted/would accept treatment by DSP comprised 88% of respondents. Performance (85.4%) and quality of treatment (85.5%) were important characteristics of DSP. The multivariable analysis revealed that increase in score rates of confidence in DSP was significantly associated with acceptance of treatment, odds ratio (OR)=1.89, 95% CI (1.48-2.43), p<0.001. Similarly, students who had a better understanding of patients’ management were more likely to accept treatment by DSP (OR=2.70, 95% CI 1.05-6.96, p=0.039).

A high percentage of students had accepted/would accept treatment by DSP. These findings also suggest that students who have confidence in DSP and those who understand patient management would accept oral health care by DSP.

A high percentage of students had accepted/would accept treatment by DSP. These findings also suggest that students who have confidence in DSP and those who understand patient management would accept oral health care by DSP.

To translate and validate the DES-10 into Chinese and adapt the DES-10 among Chinese prostate cancer patients. To explore the impact of demographic data on the SDM of Chinese prostate cancer patients.

Data were collected from December 2019 to January 2020 from four hospitals among prostatic cancer patients in Henan Province, by convenience sampling method. A demographic questionnaire, DES-10, and 9-item Shared Decision Making Questionnaire (SDM-Q-9) were administered. The exploratory and confirmatory factor analysis was carried out to test the content, construct, reliability, and concurrent validity of the translated DES-10. Then, Pearson’s correlation,

-test, and analysis of variance were used to test the demographic difference of DES-10.

A total of 380 prostatic cancer patients completed the survey (96% response rate). The total score of DES-10 was 71.16±17.14. 6-OHDA The Cronbach’s ɑ coefficient was 0.87. Single factor structure was confirmed by exploratory factor analysis (explaining 50.14% of the variance). Model fitting indexes (RMSEA=0.07, CMIN/DF=2.92) were acceptable. The DES-10 scale showed good validity with the SDM-Q-9 as the criterion. Age, marital status, homeplace, and household monthly income could affect the shared decision-making of prostatic cancer patients.

The DES-10 was demonstrated to be a valid and reliable scale to assess the prostatic cancer patient’s engagement in health care decision-making. And it is culturally appropriate for use in China. The influence of age, marital status, homeplace, and household monthly income should be considered in promoting patients’ participation in shared decision-making.

The DES-10 was demonstrated to be a valid and reliable scale to assess the prostatic cancer patient’s engagement in health care decision-making. And it is culturally appropriate for use in China. The influence of age, marital status, homeplace, and household monthly income should be considered in promoting patients’ participation in shared decision-making.

Patients who test positive on the fecal immunochemical test (FIT) for colorectal cancer (CRC) are referred for colonoscopy for further diagnostic evaluation. Colonoscopy is not a perfect method and may be a challenge for some FIT-positive patients. Computed tomographic colonography (CTC) is an alternative method that is less invasive and allows examination of the whole colon. The study objective was to evaluate the preference of FIT-positive patients for either colonoscopy or CTC for CRC examination.

Individuals older than 40 years with a positive FIT test at eight Japanese hospitals between December 2012 and July 2015 were invited to participate. Participants were given detailed information regarding colonoscopy and CTC before deciding on either examination. They completed questionnaires before the procedure regarding their preference and after the procedure regarding their experience.

The pre- and post-questionnaires of 846 and 834 participants, respectively, were analyzed. Participants preferred colonoscopy over CTC (colonoscopy, 72%; CTC, 28%).